AICAR, a Small Chemical Molecule, Primes Osteogenic Differentiation of Adult Mesenchymal Stem Cells

The chemical approach to controlling stem cell fates is emerging as a powerful tool, holding great promise in tissue engineering and regenerative medicine. Various small molecules have been demonstrated capable of modulating stem cell differentiation. In this paper, we studied the effects of 5-aminoimidazole-4-carboxamide-1-β-riboside (AICAR), an activator of AMP-activated protein kinase (AMPK), on mesenchymal stem cells (MSCs). AICAR at high concentrations (1.0–2.0 mM) significantly inhibited proliferation of both human amnion-derived MSCs (hAMSCs) and rabbit bone marrow-derived MSCs (BM-MSCs). Most importantly, AICAR efficiently promoted the osteogenic differentiation of hAMSCs and BM-MSCs in both growth medium and osteogenic medium. However, Metformin, another AMPK activator, showed no such effects. Meanwhile, AICAR significantly inhibited adipogenic differentiation of hAMSCs and BM-MSCs. Our data suggests that AICAR represents a potent molecule, which can be applied in bone tissue regeneration.

[1]  S. Ryu,et al.  Ochratoxin A inhibits adipogenesis through the extracellular signal-related kinases-peroxisome proliferator-activated receptor-γ pathway in human adipose tissue-derived mesenchymal stem cells. , 2011, Stem cells and development.

[2]  J. M. Quesada-Gomez,et al.  Oleuropein enhances osteoblastogenesis and inhibits adipogenesis: the effect on differentiation in stem cells derived from bone marrow , 2011, Osteoporosis International.

[3]  W. Tan,et al.  Clonal isolation and characterization of mesenchymal stem cells from human amnion , 2010 .

[4]  L. Altucci,et al.  Impact of histone deacetylase inhibitors SAHA and MS‐275 on DNA repair pathways in human mesenchymal stem cells , 2010, Journal of cellular physiology.

[5]  Nuno M Neves,et al.  Osteogenic induction of hBMSCs by electrospun scaffolds with dexamethasone release functionality. , 2010, Biomaterials.

[6]  Jing Hu,et al.  Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats. , 2010, European journal of pharmacology.

[7]  N. Chiba,et al.  Osteoblast differentiation is functionally associated with decreased AMP kinase activity , 2009, Journal of cellular physiology.

[8]  Yilin Cao,et al.  The role of the extracellular signal-related kinase signaling pathway in osteogenic differentiation of human adipose-derived stem cells and in adipogenic transition initiated by dexamethasone. , 2009, Tissue engineering. Part A.

[9]  L. Altucci,et al.  Histone deacetylase inhibitors promote apoptosis and senescence in human mesenchymal stem cells. , 2009, Stem cells and development.

[10]  P. Schultz,et al.  A small molecule primes embryonic stem cells for differentiation. , 2009, Cell stem cell.

[11]  S. Schreiber,et al.  Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. , 2009, Cell stem cell.

[12]  F. Nan,et al.  AMP-activated Protein Kinase Is Involved in Neural Stem Cell Growth Suppression and Cell Cycle Arrest by 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside and Glucose Deprivation by Down-regulating Phospho-retinoblastoma Protein and Cyclin D* , 2009, Journal of Biological Chemistry.

[13]  Yuzhi Zhang,et al.  AICAR activates the pluripotency transcriptional network in embryonic stem cells and induces KLF4 and KLF2 expression in fibroblasts , 2009, BMC pharmacology.

[14]  W. Tan,et al.  Influence of lactic acid on the proliferation, metabolism, and differentiation of rabbit mesenchymal stem cells , 2009, Cell Biology and Toxicology.

[15]  S. Yano,et al.  Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression. , 2008, Biochemical and biophysical research communications.

[16]  In-kyu Lee,et al.  AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast. , 2008, Bone.

[17]  J. Hyllner,et al.  Low molecular weight compounds for in vitro fate determination of human embryonic stem cells. , 2008, Pharmacological research.

[18]  Sheng Ding,et al.  A chemical approach to stem-cell biology and regenerative medicine , 2008, Nature.

[19]  F. Nan,et al.  AICAR Induces Astroglial Differentiation of Neural Stem Cells via Activating the JAK/STAT3 Pathway Independently of AMP-activated Protein Kinase* , 2008, Journal of Biological Chemistry.

[20]  S. Yano,et al.  Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells , 2007, BMC Cell Biology.

[21]  S. Hung,et al.  Sodium butyrate activates ERK to regulate differentiation of mesenchymal stem cells. , 2007, Biochemical and biophysical research communications.

[22]  C. V. van Blitterswijk,et al.  Inhibition of histone acetylation as a tool in bone tissue engineering. , 2006, Tissue engineering.

[23]  E. Roche,et al.  Role of small bioorganic molecules in stem cell differentiation to insulin-producing cells. , 2006, Bioorganic & medicinal chemistry.

[24]  A. Cortizo,et al.  Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. , 2006, European journal of pharmacology.

[25]  S. Tilghman,et al.  Phosphoenolpyruvate carboxykinase and the critical role of cataplerosis in the control of hepatic metabolism , 2005, Nutrition & metabolism.

[26]  H. Xie,et al.  Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. , 2005, Experimental cell research.

[27]  I. Kang,et al.  5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages. , 2004, Biochemical and biophysical research communications.

[28]  G. Plopper,et al.  ERK Signaling Pathways Regulate the Osteogenic Differentiation of Human Mesenchymal Stem Cells on Collagen I and Vitronectin , 2004, Cell communication & adhesion.

[29]  Peter G. Schultz,et al.  Synthetic small molecules that control stem cell fate , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  D. Pipeleers,et al.  AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. , 2003, Journal of molecular endocrinology.

[31]  A. Santidrián,et al.  5-Aminoimidazole-4-carboxamide riboside induces apoptosis in Jurkat cells, but the AMP-activated protein kinase is not involved. , 2003, The Biochemical journal.

[32]  D. Pipeleers,et al.  AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase , 2003, Diabetologia.

[33]  Peter G Schultz,et al.  A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells. , 2002, Journal of the American Chemical Society.

[34]  M. Pittenger,et al.  Adult Human Mesenchymal Stem Cell Differentiation to the Osteogenic or Adipogenic Lineage Is Regulated by Mitogen-activated Protein Kinase* , 2000, The Journal of Biological Chemistry.

[35]  E. Holmes,et al.  5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells. , 1985, The Journal of biological chemistry.

[36]  D. Pipeleers,et al.  AMP-activated protein kinase can induce apoptosis of insulin-producing MIN 6 cells through stimulation of c-Jun-N-terminal kinase , 2003 .